An outbreak of the Bundibugyo virus disease (BVD) has been reported.

A weekly external situation report details an ongoing outbreak of Ebola Bundibugyo virus disease in the Democratic Republic of Congo and Uganda, with data updated as of July 19, 2026.

A commentary highlights that the current Bundibugyo virus epidemic, a form of Ebola, should not have caught the world off guard, according to Medecins Sans Frontieres Secretary-General Laura Leyser.

An American citizen working for a humanitarian organization in Africa was admitted to a university hospital in Frankfurt, Germany, after contracting the Bundibugyo variant of the Ebola virus.

Clinical trials have commenced in the Democratic Republic of Congo, focusing on the Bundibugyo strain of Ebola. The trials are taking place in the epicenter of the outbreak, marking a significant step in combating the disease.

Congolese health authorities report a significant rise in recoveries from Bundibugyo Ebola, allowing doctors to better understand the virus's behavior even as new patients are admitted daily.

An outbreak of the Ebola Bundibugyo virus disease has been reported in the Democratic Republic of the Congo and Uganda, leading to a response from the European Union.

A Disease Outbreak News report confirms an Ebola disease outbreak caused by the Bundibugyo virus in the Democratic Republic of the Congo and Uganda.

Following the World Health Organization's declaration of a public health crisis due to the Bundibugyo virus outbreak in Africa, internet users are creating new conspiracy theories, questioning why Moderna announced its involvement in vaccine development six months before the Ebola outbreak.

Scientists are aiming to begin human trials for a new Ebola vaccine candidate against the deadly Ebola Bundibugyo strain within months, following a surge in funding.

Reakcja na pojawienie się wirusa ebola była spóźniona - ocenił szef Afrykańskich Centrów Kontroli i Zapobiegania Chorobom. W Demokratycznej Republice Konga i w Ugandzie przybywa zakażeń.

Ebola Alert: India And US Step Up Airport Screening; WHO Warns Bundibugyo Vaccine Could Take Months  Dailyhunt

India has developed and is implementing RT-PCR tests specifically designed to detect the Bundibugyo strain of the Ebola virus, enhancing its diagnostic capabilities for this particular variant.

Chinese researchers have developed an Ebola vaccine using mRNA technology, similar to that used for Covid-19. Animal trials have shown the vaccine to be effective against the currently devastating Bundibugyo strain.

Vaccines and antivirals with potential against the Bundibugyo Ebola virus, responsible for the current outbreak, are under development, though most have only been studied in animals.

El virus se propaga de la misma manera que otros virus del ébola: por contacto cercano con fluidos corporales de pacientes enfermos o fallecidos, como sudor, sangre, heces o vómito Leer

WHO declares global emergency over rare Bundibugyo Ebola strain MSN

The Bundibugyo virus outbreak in the Democratic Republic of Congo has worsened, with cases reaching 4,665 and expanding across 54 health zones in six provinces, making it the largest Ebola outbreak reported in the country.

The Ervebo vaccine has proven safe and effective against the common Zaire strain of the Ebola virus, with early data suggesting it may also protect against the rarer Bundibugyo strain, potentially leading to public availability in DR Congo.

Moderna has initiated the first human trial for its vaccine targeting the Bundibugyo strain of the Ebola virus.

Oxford University has initiated the first human trial for a vaccine targeting the Bundibugyo strain of the Ebola virus, marking a significant step in vaccine development.

In Congo's Ituri province, two new medicines for the Bundibugyo variant of the Ebola virus are being tested on patients, in an international initiative aimed at reducing mortality rates.

With aid funding for HIV response falling by 70%, Africa is urged to take control of its own terms to end AIDS, treating health as a matter of sovereignty rather than charity. The Bundibugyo Ebola outbreak further highlights the continent's health challenges.

G7 leaders have called for a strong and coordinated international response to the spreading Ebola outbreak in the Democratic Republic of Congo and Uganda. Discussions also included the potential for new Ebola Bundibugyo vaccine candidates to enter Phase 1 trials soon.

The Coalition for Epidemic Preparedness Innovations (CEPI) has invested $1.9 million to speed up the development of an Ebola vaccine. This initiative comes as the Bundibugyo outbreak has led to over 560 confirmed infections and more than 100 deaths.

The Nigeria Centre for Disease Control (NCDC) has appealed to state governors to boost funding for health workers to prevent the Bundibugyo strain of Ebola from entering the country.

An article explains what to know about the Bundibugyo virus and why a vaccine is not an immediate solution, highlighting the complexities of developing a preventative measure.

EU aid and global response intensify as Bundibugyo Ebola spreads  MSN

The World Health Organization has released updated figures, indicating 906 suspected cases and 223 suspected deaths attributed to the Bundibugyo strain of Ebola.

The Department of Health confirmed that the Philippines has no reported cases of Ebola, despite a growing outbreak of the Ebola Bundibugyo virus in parts of Africa.

Ugandans are expressing regret over the association of their Bundibugyo district with a type of the Ebola virus, which was named after the region of cocoa farmers. The naming has created an unwanted link for the local population.

Research and development efforts are currently underway to create specific vaccines and treatments for the Bundibugyo strain of the Ebola virus.

What to know about the Bundibugyo virus, a species of Ebola causing an outbreak in Congo - Africa - World  Ahram Online

Recent explainers detail the current knowledge surrounding the Bundibugyo strain of the Ebola virus. These reports aim to inform the public about this specific variant of the deadly disease.

Scientists have developed an experimental vaccine that successfully protected mice against three species of Ebola, including the Bundibugyo strain. New studies reveal the Bundibugyo strain is less lethal than the Zaire strain, killing 30% to 40% of infected people, while the vaccine still requires human testing.

WHO warns of rapid spread in Ebola Bundibugyo outbreak MSN

The Batwa community in Bundibugyo, Uganda, is actively working to improve access to education for its members.

The World Health Organization has recommended a Phase III trial for an Ebola vaccine specifically targeting the Bundibugyo virus. This recommendation comes as researchers develop vaccines and treatments for the ongoing outbreak in the Democratic Republic of the Congo.

The World Health Organization has recommended a clinical trial for an Ebola vaccine, following preliminary animal study data suggesting it may offer cross-protection and reduce deaths from the Bundibugyo virus.

The World Health Organization (WHO) has noted progress in studies for drugs and vaccines targeting the Bundibugyo variant of Ebola, with 75 patients testing medications. However, even in the best-case scenario, regulatory approval could still be months away.

A new vaccine targeting the Bundibugyo strain of the Ebola virus, which has been devastating the Democratic Republic of the Congo, has begun human clinical trials.

Oxford University has initiated the first human trials for a vaccine targeting the Bundibugyo strain of the Ebola virus. This comes as the majority of new Ebola cases in eastern Congo are from unknown chains, indicating the outbreak is outpacing the response.

Oxford University has launched the first human trial of a new Bundibugyo Ebola vaccine, as the outbreak continues to spread in the Democratic Republic of Congo. This trial is a critical step in combating the deadly virus.

Patients have begun enrolling in the PARTNERS trial in the Democratic Republic of the Congo, marking the world's first scientific effort to test treatments for Bundibugyo virus disease.

Scientists are working to identify the animal species responsible for the Bundibugyo Ebola virus, which occasionally spills over into humans, as the origin of the outbreak remains a central mystery.

An update on the Ebola Bundibugyo virus disease outbreak in the Democratic Republic of the Congo and Uganda, including the European Union's response efforts.

An article provides essential information about the Bundibugyo virus, highlighting the complexities and reasons why an immediate vaccine solution is not available.

Research and development efforts are currently focused on creating vaccines and treatments specifically for the Bundibugyo strain of the Ebola virus.

India has issued a travel advisory and implemented Ebola screening guidelines for passengers arriving from Uganda and the Democratic Republic of Congo. This measure follows a WHO emergency alert regarding an Ebola Bundibugyo outbreak.

DR Congo: No approved vaccine for Bundibugyo variant of Ebola say health authorities Newsonair

An Ebola outbreak is causing increased concern due to a suspected undercount of cases. Meanwhile, the World Health Organization announced that an approved vaccine for the rare Bundibugyo strain is still several months from availability.

An informational piece delves into what is known about the Bundibugyo strain of the Ebola virus, providing details on its characteristics and impact.

International health experts have gathered to explore and identify potential vaccine options for the Ebola Bundibugyo strain, aiming to advance global efforts in combating the deadly virus.

WHO declares Ebola Bundibugyo outbreak a global health emergency MSN

In Bundibugyo, Uganda, the influx of money from cocoa production is paradoxically contributing to an education crisis, suggesting that economic gains are not translating into improved educational outcomes for the region.